Engineers Gate Manager LP Tricida, Inc. Transaction History

Engineers Gate Manager LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.95 - $5.41 $105,808 - $144,917	-26,787 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.52 - $7.8 $268,343 - $463,070	-59,368 Reduced 68.91%	26,787 $142,000
Q4 2020 Feb 16, 2021	SELL	$4.37 - $9.46 $74,346 - $160,942	-17,013 Reduced 16.49%	86,155 $607,000
Q3 2020 Nov 16, 2020	BUY	$8.56 - $26.93 $630,606 - $1.98 Million	73,669 Added 249.73%	103,168 $935,000
Q2 2020 Aug 17, 2020	SELL	$21.21 - $31.55 $308,350 - $458,673	-14,538 Reduced 33.01%	29,499 $811,000
Q1 2020 May 15, 2020	BUY	$18.43 - $38.04 $54,552 - $112,598	2,960 Added 7.21%	44,037 $969,000
Q4 2019 Feb 14, 2020	BUY	$29.6 - $43.71 $545,350 - $805,313	18,424 Added 81.33%	41,077 $1.55 Million
Q3 2019 Nov 14, 2019	SELL	$29.87 - $42.22 $308,437 - $435,963	-10,326 Reduced 31.31%	22,653 $699,000
Q2 2019 Aug 14, 2019	BUY	$31.16 - $39.46 $1.03 Million - $1.3 Million	32,979 New	32,979 $1.3 Million

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.